Literature DB >> 16957179

Coordinated control of bile acids and lipogenesis through FXR-dependent regulation of fatty acid synthase.

Karen E Matsukuma1, Mary K Bennett, Jiansheng Huang, Li Wang, Gregorio Gil, Timothy F Osborne.   

Abstract

We discovered a nuclear receptor element in the FAS promoter consisting of an inverted repeat spaced by one nucleotide (IR-1) and located 21 bases downstream of a direct repeat sequenced by 4 nucleotides (DR-4) oxysterol liver X receptor response element. An IR-1 is present in promoters of several genes of bile acid and lipid homeostasis and binds farnesoid X receptor/retinoid X receptor (FXR/RXR) heterodimers to mediate bile acid-dependent transcription. We show that FXR/RXRalpha specifically binds to the FAS IR-1 and that the FAS promoter is activated approximately 10-fold by the addition of a synthetic FXR agonist in transient transfection assays. We also demonstrate that endogenous FXR binds directly to the murine FAS promoter in the hepatic genome using a tissue-based chromatin immunoprecipitation procedure. Furthermore, we show that feeding wild-type mice a chow diet supplemented with the natural FXR agonist chenodeoxycholic acid results in a significant induction of FAS mRNA expression. Thus, we have identified a novel IR-1 in the FAS promoter and demonstrate that it mediates FXR/bile acid regulation of the FAS gene. These findings provide the first evidence for direct regulation of lipogenesis by bile acids and also provide a mechanistic rationale for previously unexplained observations regarding bile acid control of FAS expression.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16957179     DOI: 10.1194/jlr.M600342-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  23 in total

Review 1.  Management of NAFLD: a stage-based approach.

Authors:  Mary E Rinella; Arun J Sanyal
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-02-24       Impact factor: 46.802

2.  Transgenic expression of cholesterol 7alpha-hydroxylase in the liver prevents high-fat diet-induced obesity and insulin resistance in mice.

Authors:  Tiangang Li; Erika Owsley; Michelle Matozel; Peter Hsu; Colleen M Novak; John Y L Chiang
Journal:  Hepatology       Date:  2010-08       Impact factor: 17.425

3.  Aldo-keto reductase 1B7 is a target gene of FXR and regulates lipid and glucose homeostasis.

Authors:  Xuemei Ge; Liya Yin; Huiyan Ma; Tiangang Li; John Y L Chiang; Yanqiao Zhang
Journal:  J Lipid Res       Date:  2011-06-05       Impact factor: 5.922

Review 4.  Bile Acid Metabolism in Liver Pathobiology.

Authors:  John Y L Chiang; Jessica M Ferrell
Journal:  Gene Expr       Date:  2018-01-11

5.  Effects of farnesoid X receptor on the expression of the fatty acid synthetase and hepatic lipase.

Authors:  Li-Li Shen; Hong Liu; Jiahe Peng; Lin Gan; Li Lu; Qian Zhang; Liangpeng Li; Fengtian He; Yu Jiang
Journal:  Mol Biol Rep       Date:  2010-04-07       Impact factor: 2.316

Review 6.  Nuclear receptors and nonalcoholic fatty liver disease.

Authors:  Matthew C Cave; Heather B Clair; Josiah E Hardesty; K Cameron Falkner; Wenke Feng; Barbara J Clark; Jennifer Sidey; Hongxue Shi; Bashar A Aqel; Craig J McClain; Russell A Prough
Journal:  Biochim Biophys Acta       Date:  2016-03-04

7.  Genetic ablation of Cyp8b1 preserves host metabolic function by repressing steatohepatitis and altering gut microbiota composition.

Authors:  Jay V Patankar; Chi K Wong; Vijay Morampudi; William T Gibson; Bruce Vallance; George N Ioannou; Michael R Hayden
Journal:  Am J Physiol Endocrinol Metab       Date:  2017-10-24       Impact factor: 4.310

8.  Genome-wide interrogation of hepatic FXR reveals an asymmetric IR-1 motif and synergy with LRH-1.

Authors:  Hansook Kim Chong; Aniello M Infante; Young-Kyo Seo; Tae-Il Jeon; Yanqiao Zhang; Peter A Edwards; Xiaohui Xie; Timothy F Osborne
Journal:  Nucleic Acids Res       Date:  2010-05-18       Impact factor: 16.971

Review 9.  Bile acid receptors in non-alcoholic fatty liver disease.

Authors:  Yuanyuan Li; Kavita Jadhav; Yanqiao Zhang
Journal:  Biochem Pharmacol       Date:  2013-08-26       Impact factor: 5.858

10.  Genome-wide transcriptome analysis identifies novel gene signatures implicated in human chronic liver disease.

Authors:  Rana V Smalling; Don A Delker; Yuxia Zhang; Natalia Nieto; Michael S McGuiness; Shuanghu Liu; Scott L Friedman; Curt H Hagedorn; Li Wang
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-06-27       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.